RA
BIOA

Royce & Associates’s BioAmber Inc. BIOA Stock Holding History

Royce & Associates’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-774,879
Closed -$1.99M – 1280
2017
Q2 		$1.99M Hold
774,879
– – 0.01% 842
2017
Q1 		$1.8M Sell
774,879
-50,000
-6% -$190K 0.01% 886
2016
Q4 		$4.54M Buy
824,879
+40,000
+5% +$192K 0.03% 606
2016
Q3 		$3.33M Sell
784,879
-180,000
-19% -$665K 0.02% 696
2016
Q2 		$2.88M Hold
964,879
– – 0.02% 740
2016
Q1 		$4.05M Buy
964,879
+43,000
+5% +$180K 0.03% 673
2015
Q4 		$5.7M Sell
921,879
-99,100
-10% -$747K 0.03% 587
2015
Q3 		$5.46M Buy
1,020,979
+72,000
+8% +$476K 0.03% 623
2015
Q2 		$8.16M Buy
948,979
+329,800
+53% +$3.02M 0.03% 616
2015
Q1 		$5.39M Buy
619,179
+52,054
+9% +$457K 0.02% 731
2014
Q4 		$4.76M Buy
567,125
+400,746
+241% +$3.65M 0.02% 796
2014
Q3 		$1.66M Buy
166,379
+1,400
+0.8% +$16.4K 0.01% 1045
2014
Q2 		$1.64M Hold
164,979
– – ﹤0.01% 1073
2014
Q1 		$1.89M Buy
164,979
+59,979
+57% +$711K 0.01% 1060
2013
Q4 		$785K Buy
+105,000
New +$719K ﹤0.01% 1194

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates's BIOA Position: Q3 2017 in Review

Royce & Associates sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 774,879 shares — an estimated $1.99M sold.

Royce & Associates first reported a position in BIOA in Q4 2013 and held it in 15 quarters. The position peaked at $8.16M in Q2 2015. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

  • Royce & Associates reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
  • Royce & Associates sold 774,879 BioAmber Inc. shares in Q3 2017, an estimated $1.99M.
  • Royce & Associates first reported a position in BioAmber Inc. in Q4 2013 and held it in 15 quarters.
  • Royce & Associates's BioAmber Inc. position peaked at $8.16M in Q2 2015.
  • 30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on Royce & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.